Compremium CPMX-1

FDA cleared, clinically validated, commercially available
Non-invasive diagnostics for Soft Tissue Management in trauma, orthopaedics, and emergency care with proven accuracy and reliability. The Compremium CPMX-1 gives you “Clarity through Quantification”
Available immediately in the U.S. / EU CE Mark expected
October 2025
A white light hanging from the ceiling in the dark.

The Clinical Risk of Inaccurate or Delayed Diagnostics

Delays compromise patient outcomes.

Soft tissue misjudgement can add 5 – 10 hospital days...

Giannoudis PV, et al. “Soft tissue assessment and surgical timing in fractures.” Injury. 2006.

... $20K – $100K in cost...

Healthcare Cost and Utilization Project (HCUP), 2019; AAOS Cost of Complications Report.

.... and cause permanent complications in 1 in 3 patients.

Elliott KG, Johnstone AJ. “Diagnosing acute compartment syndrome.” J Bone
Joint Surg Br. 2003.

Meet the Compremium CPMX-1

The First Non-Invasive Device for Soft Tissue Management with Unmatched Accuracy.
The Compremium CPMX-1 is redefining clinical diagnostics for Soft Tissue Management with a breakthrough non-invasive approach that delivers reliable results in seconds.
Purpose-built for trauma, orthopaedic, and emergency teams, it’s changing the way critical decisions are made.

Working with the Compremium
CPMX-1

From Scan to Diagnosis in Three Steps.

Rapid acquisition, AI-assisted analysis, and immediate reporting.

Measure

Get a real-time compressibility measurement in less than 30 seconds

Monitor

Track over time and analyze patterns to inform predictive diagnoses

Manage

Make confident intervention decisions that enable better patient outcomes

Seamless Diagnostics Across
the Continuum of Care

The Compremium CPMX-1 ensures Accuracy, Objectivity
and Actionable Insights in every setting.

Identify, monitor and triage high risk soft tissue injury

Surgical planning based on objective soft tissue assessment

Post-operative follow-up for soft tissue recovery

Evidence That Meets the Highest Standards

Endorsed by Clinical Leaders.
Backed by competent authorities and published in top-tier medical journals.

Testimonials

Prof. Dr. Ulrich Stöckle, Charité – Universitätsmedizin Berlin

The CPMX1 is able to monitor precisely, non-invasively muscle compressibility and tissue pressure. These reliable data are a big step forward in providing the best care for our patients in an urgent medical need.

Specialists in Critical
Diagnostics

Led by Experts in Trauma Care & Medical Device Engineering
Our leadership combines decades of clinical practice, product development, and regulatory navigation.

Meet the
team

Vincent Baumann

Chief Executive Officer

Healthcare leader with 20 years of experience

Ulrich Baumann, MD

Chief Medical Officer

Passionate medical doctor for 40+ years

Aswin Bhuvanendran

Chief Commercial Officer

Commercial leader in life sciences for 15+ years

Patrick Roth

Chief Operations Officer

25 years in MedTech and other industries

Kolaleh Eskandanian

Chief Strategy and Innovation Officer, Head of Pediatrics

Robin Demesmaeker

Chief Technology Officer

Medtech innovator and accelerator for 8+ years

Vicky Word

US Clinical Operations Lead

Damon Judges

Clinical Operations Manager

Jorge J. Herrero

Commercial Development Manager Europe

Theresa Joost

Scientific Marketing & Sales

+10 years of interdisciplinary clinical expertise combined with passion for advancing innovation in medtech & empowering through knowledge

Federico Milani

Head of Software Development

Software engineer with 4+ years of specialized expertise in Artificial Intelligence and Computer Vision